477 related articles for article (PubMed ID: 26672650)
1. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
Mittal L; Suzuki J
Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
[TBL] [Abstract][Full Text] [Related]
2. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
[TBL] [Abstract][Full Text] [Related]
3. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
4. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
5. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Johnson S; Martin PR
Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
[TBL] [Abstract][Full Text] [Related]
6. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
Meyer MC; Johnston AM; Crocker AM; Heil SH
J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
[TBL] [Abstract][Full Text] [Related]
7. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
9. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
10. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
11. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
12. Opioid Management in Pregnancy and Postpartum.
Brown HL
Obstet Gynecol Clin North Am; 2020 Sep; 47(3):421-427. PubMed ID: 32762927
[TBL] [Abstract][Full Text] [Related]
13. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
[TBL] [Abstract][Full Text] [Related]
14. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.
Higgins TM; Goodman DJ; Meyer MC
Prev Med; 2019 Nov; 128():105786. PubMed ID: 31356827
[TBL] [Abstract][Full Text] [Related]
15. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL; Rayburn WF
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
[TBL] [Abstract][Full Text] [Related]
17. Chronic opioid use during pregnancy: maternal and fetal implications.
Stanhope TJ; Gill LA; Rose C
Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention.
Ray-Griffith S; Tharp E; Coker JL; Catlin D; Knight B; Stowe ZN
Am J Addict; 2021 Jan; 30(1):43-48. PubMed ID: 32673447
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
[TBL] [Abstract][Full Text] [Related]
20. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
